Kimura E, Penaia L, Samarawickrema W A, Spears G F
Bull World Health Organ. 1985;63(6):1089-96.
Among microfilaria (mf) carriers of subperiodic bancroftian filariasis in Samoa, the low-density level of microfilaraemia was defined as 1-20 mf/ml, and the occurrence of low-density carriers (90 in the present study) was analysed by age, sex, and village in relation to the microfilarial prevalence rate. The low-density carriers were more numerous among those under 20 years and over 60 years old than in other age groups. The ratio of low-density carriers to the total of mf-positive subjects in a village decreased as the prevalence rate of Wuchereria bancrofti in the village increased.The epidemiological significance of low-density carriers was assessed in connection with the infectivity of vector mosquitos (Aedes polynesiensis) produced by them, the possible change of these carriers to carriers of a higher density, and the production of new low-density carriers by diethylcarbamazine citrate (DEC-C) treatment. The mosquito infectivity produced by the low-density carriers accounted for only 2.16% of the total infectivity produced by all the carriers, suggesting that these carriers are of minor importance in the transmission of filariasis. The change of microfilarial count over time among untreated mf-positive subjects was not remarkable during a 60-252-day observation period. However, the low-density carrier group showed a mean increase of 36%, the younger such carriers (under 30 years old) showing a 132% increase. The production of low-density carriers by DEC-C single-dose treatment (6 mg/kg body weight) was not as great as expected.
在萨摩亚亚周期班氏丝虫病的微丝蚴(mf)携带者中,微丝蚴血症的低密度水平定义为1 - 20 mf/ml,并按年龄、性别和村庄分析低密度携带者(本研究中有90例)的出现情况与微丝蚴流行率的关系。20岁以下和60岁以上人群中的低密度携带者比其他年龄组更多。随着村庄中班氏吴策线虫流行率的增加,村庄中低密度携带者与mf阳性受试者总数的比例下降。结合这些携带者产生的媒介蚊子(波利尼西亚伊蚊)的感染性、这些携带者可能转变为高密度携带者以及柠檬酸乙胺嗪(DEC - C)治疗产生新的低密度携带者的情况,评估了低密度携带者的流行病学意义。低密度携带者产生的蚊子感染性仅占所有携带者产生的总感染性的2.16%,这表明这些携带者在丝虫病传播中重要性较小。在60 - 252天的观察期内,未经治疗的mf阳性受试者的微丝蚴计数随时间的变化并不显著。然而,低密度携带者组平均增加了36%,较年轻的此类携带者(30岁以下)增加了132%。DEC - C单剂量治疗(6 mg/kg体重)产生的低密度携带者数量不如预期的多。